ArticleThe Journal of clinical investigation2002

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.

Valérie Dutoit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.